as to how this is so OBVIOUS ... suit makes the same heavy acusations that have brought down government contractors. Are you privy to Omeros H.R./ recruiter process on this CFO coming in to help the company get a going public process in order culminating with the original S-1's filed long before the markets busted for anything risky.
With the sting still fresh the market does not look kindly at risk. Don't know if its all this CFO talk, the science, disbelievers in the IP that is sending RISK, RISK, RISK signals to the market for new equity into biotechs.
Only thing we know is the post IPO share price has been ugly, ugly, ugly